Nomura Holdings Inc Atara Biotherapeutics, Inc. Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $120,064 - $251,904	-25,600 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$8.44 - $16.89 $4,945 - $9,897	586 Added 2.34%	25,600 $243,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $8,614 - $11,655	-586 Reduced 2.29%	25,014 $394,000
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $42,000 - $62,160	3,000 Added 13.27%	25,600 $368,000
Q3 2020 Nov 12, 2020	BUY	$11.92 - $15.87 $95,360 - $126,960	8,000 Added 54.79%	22,600 $292,000

Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $109,938 - $217,978	14,600 New	14,600 $212,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.